1-4 of 4
L Ludwig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Modeling Targeted Lymphodepletion with Radiolabeled CD45 Antibody As a Promising Preparative Regimen Prior to Adoptive Cell Therapy or CAR-T

Dale L Ludwig, PhD BS, Mark S. Berger, MD, Dadachova Ekaterina, PhD, Kevin Allen, PhD, Wojciech Dawicki
Journal: Blood
Blood (2018) 132 (Supplement 1): 5682.
https://doi.org/10.1182/blood-2018-99-119740
Published: 2018
Journal Articles

HoxA9 Induces Insulin-Like Growth Factor-1 Receptor (IGF-1R) Expression in Acute Leukemia.

Jarrett T. Whelan, BS, Dale L. Ludwig, Ph.D., Fred E. Bertrand, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3343.
https://doi.org/10.1182/blood.V110.11.3343.3343
Published: 2007
Journal Articles

Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody

Yiwen Li, Hongli Li, Mei-Nai Wang, Dan Lu, Rajiv Bassi, Yan Wu, Haifan Zhang, Paul Balderes, Dale L. Ludwig, Bronislaw Pytowski, Paul Kussie, Obdulio Piloto, Donald Small, Peter Bohlen, Larry Witte, Zhenping Zhu, Daniel J. Hicklin
Journal: Blood
Blood (2004) 104 (4): 1137–1144.
https://doi.org/10.1182/blood-2003-07-2585
Published: 2004
Includes: Supplemental data
Journal Articles

Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood

M Wada, CR Bartram, H Nakamura, M Hachiya, DL Chen, J Borenstein, CW Miller, L Ludwig, TE Hansen-Hagge, WD Ludwig
Journal: Blood
Blood (1993) 82 (10): 3163–3169.
https://doi.org/10.1182/blood.V82.10.3163.3163
Published: 1993